New Animal Drugs For Use In Animal Feeds; Narasin and Nicarbazin With Roxarsone

摘要

The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a new animal drug application (NADA) filed by Elanco Animal Health, a Division of Eli Lilly and Co. The NADA provides for combining approved narasin/nicarbazin (1:1 fixed ratio) and roxarsone type A medicated articles to make combination drug type C medicated broiler chicken feeds for prevention of coccidiosis, for increased rate of weight gain, improved feed efficiency, and improved pigmentation.